Serum Institute Of India Stops Trials, Will Wait For DCGI Approval

Serum Institute of India will stop its COVID-19 Oxford vaccine trials till further notice by the Drug Controller General of India, the company stated. On September 9,the DCGI issued a show cause notice to the company after it stated that it would continue trials even after AstraZeneca, the primary manufacturer said that they were halting their trials.

A patient in UK developed a suspected adverse reaction and AstraZeneca is set to review whether the illness was due to the vaccine.